Sonepcizumab
Sonepcizumab (LT 1009) is a fully humanized anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC).
Read more
€0.00
(tax incl.)
Reference:
HY-P99318
Brand: